AUGMENTED INTELLIGENCE IN DRUG DISCOVERY XCHANGE
Boston
June 20, 2024

Welcome to hubXchange’s Augmented Intelligence (AI) in Drug Discovery Xchange Boston 2024, bringing together executives from pharma and biotech to address and find solutions to the key issues faced in AI-led drug discovery.

Discussion topics will cover Data Quality, Target Identification, Lead Generation & Lead Optimization and Drug Response Prediction.

Take advantage of this unique highly interactive meeting format designed for maximum engagement, collaboration and networking with your peers.

Please note this is an In-Person meeting.

VENUE DETAILS: Woburn Hilton Hotel, 2 Forbes Road, Woburn, MA, 01801, US

SNAPSHOTS OF DISCUSSION TOPICS

  • Data FAIRification, and the overall digitalization through digital. transformation.
  • Novel Data Quality approaches.
  • Leveraging multimodal data fusion for target discovery.
  • Building a target discovery engine: key ingredients and how to mix them.
  • Taking advantage of new methods in lead generation and optimization.
  • Expanding and measuring applicability domains in machine learning.
  • Enhancing drug response prediction using AI.

Full Xchange Agenda

Click on each track for detailed agenda

Data Quality

Time
Titles and Bullets
Facilitator
8:00 – 8:30
Registration
8:30 – 9:00

Opening Address & Keynote Presentation by Optibrium

 

9:05 – 10:05
Data FAIRification, and the overall digitalization through digital transformation.
10:10 – 10:40
1-2-1 Meetings / Networking Break
10:40 – 11:10
1-2-1 Meetings / Networking Break
11:10 – 11:20
Morning Refreshments
11:20 – 12:20
Computational best practices in data quality for AI/ML development.
12:20– 13:20

Networking Lunch

13:20– 13:50

Spotlight Presentation by Drugbank

13:55 – 14:25

1-2-1 Meetings / Networking Break

14:25 – 14:55

1-2-1 Meetings / Networking Break

14:55 – 15:05

Afternoon Refreshments

15:05 – 15:35
Sponsor Led Poster Presentation
15:40– 16:40
Novel Data Quality approaches.
16:40– 17:40

Drinks-Canape Reception

Partners

AI in Drug Discovery Xchange | Boston 2024
Register